Clofarabine versus fludarabine‐based reduced‐intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS

We have retrospectively compared survivals between acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS) patients who received either a clofarabine/busulfan (CloB2A2) or a fludarabine/busulfan (FB2A2) RIC regimen for allogeneic stem cell transplantation. Between 2009 and 2014, 355 allotranspla...

Descripción completa

Detalles Bibliográficos
Autores principales: Chevallier, Patrice, Labopin, Myriam, de La Tour, Regis Peffault, Lioure, Bruno, Bulabois, Claude‐Eric, Huynh, Anne, Blaise, Didier, Turlure, Pascal, Daguindau, Etienne, Maillard, Natacha, Yakoub‐Agha, Ibrahim, Guillerm, Gaelle, Delage, Jeremy, Contentin, Nathalie, Bay, Jacques‐Olivier, Beckerich, Florence, Bourhis, Jean‐Henri, Detrait, Marie, Vigouroux, Stéphane, François, Sylvie, Legrand, Faezeh, Guillaume, Thierry, Mohty, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119961/
https://www.ncbi.nlm.nih.gov/pubmed/27748046
http://dx.doi.org/10.1002/cam4.880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119961/
https://www.ncbi.nlm.nih.gov/pubmed/27748046
http://dx.doi.org/10.1002/cam4.880

Ejemplares similares